Chinese medicine ligustrazine combined with percutaneous transhepatic tumor intramuscular injection of lipiodol pirarubicin combined with transhepatic arterial chemotherapy in advanced liver cancer and safety observation
10.3969/j.issn.1005-1678.2017.06.030
- VernacularTitle:中药川芎嗪联合经皮肝穿瘤内注射碘油吡柔比星联合肝动脉化疗中晚期肝癌的疗效及安全性观察
- Author:
Caixia ZHENG
;
Qingzheng JIN
- Keywords:
ligustrazine phosphate tablets;
percutaneous intratumoral injection of lipiodol THPr;
advanced liver cancer;
chemotherapy
- From:
Chinese Journal of Biochemical Pharmaceutics
2017;37(6):84-86
- CountryChina
- Language:Chinese
-
Abstract:
Objective Observing the clinical effect of Ligustrazine Phosphate Tablets combined with percutaneous intratumoral injection of lipiodol THP on advanced hepa-tocellular carcinoma.Methods83 patients with advanced hepatocellular carcinoma from January 2012 to September 2014 were analyzed.Double-blind, randomized method All patients were divided into the control group 41 cases and observation group 42 cases.The control group were treatedwith percutaneous transhepatic intratumoral injection of lipiodol THP, the observation groupwere given Ligustrazine Phosphate Tablets combined with percutaneous intratumoral injection of lipiodol THP to treat.After treatment, the two groups of patients with treatment efficacy, adverse reactions and Karnofsky and prothrombin time were analyzed.ResultsAftertreatment, the efficacy of the two groups of patients were compared, the results showed that patients in the observation group total effective rate of the control group (χ2=4.034),the difference was statistically significant (P<0.05);two groups adverse reactions in patients after treatment were compared, liver pain, blood toxicity, fever, gastrointestinal reactions similar proportion of patients, the difference was not statistically significant;Theproportion of patients in the observation group AFP<8.1ng/mL was significantly higher (χ2=4.338), the difference was statistically significant (P<0.05);patients were observed after treatment Karnofsky score was significantly higher, the difference was statistically significant (t=7.141, P<0.05);after two groups of patients were compared prothrombin time, the difference was not statistically significant.ConclusionHepatic arterial chemoembolization and percutaneous intratumoral injection of THP lipiodol emulsion on the basis of the combination of Ligustrazine Phosphate Tablets can effectively improve the efficacy of treatment, and has good security, which is a safe and effective methods of treatment should be to promote and use in clinical.
